Polyphenol-induced dissociation of various amyloid fibrils results in a methionine-independent formation of ROS

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 11, 2008, Pages 1570-1577

  Shoval, Hila ^a   Weiner, Lev ^b   Gazit, Ehud ^a   Levy, Michal ^a   Pinchuk, Ilya ^a   Lichtenberg, Dov ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Amyloid disease; Electron spin resonance; Fibril dissociation; Free radicals; Polyphenols; Self Assembly

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; CURCUMIN; METHIONINE; PEROXIDE; POLYPEPTIDE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; TRANSITION ELEMENT;

ARTICLE; CHEMICAL REACTION; DISSOCIATION; ELECTRON MICROSCOPY; ELECTRON SPIN RESONANCE; KINETICS; PRIORITY JOURNAL; SPECTROFLUOROMETRY;

AMYLOID; CATECHIN; CURCUMIN; FLAVONOIDS; HUMANS; KINETICS; METHIONINE; MODELS, BIOLOGICAL; PEROXIDES; PHENOLS; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 54049103538     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2008.08.007     Document Type: Article

References (40)

1. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
2. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., and Butterfield D.A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3270-3274
3. Tabner B.J., Turnbull S., El Agnaf O., and Allsop D. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr. Top. Med. Chem. 1 (2001) 507-517
4. Dyrks T., Dyrks E., Hartmann T., Masters C., and Beyreuther K. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267 (1992) 18210-18217
5. Schoneich C. Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease. Biochim. Biophys. Acta 1703 (2005) 111-119
6. Shoval H., Lichtenberg D., and Gazit E. The molecular mechanisms of the anti-amyloid effects of phenols. Amyloid. 14 (2007) 73-87
7. Nunomura A., Castellani R.J., Zhu X., Moreira P.I., Perry G., and Smith M.A. Involvement of oxidative stress in Alzheimer disease. J. Neuropathol. Exp. Neurol. 65 (2006) 631-641
8. Nakamura M., Shishido N., Nunomura A., Smith M.A., Perry G., Hayashi Y., Nakayama K., and Hayashi T. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Biochemistry 46 (2007) 12737-12743
9. Kontush A. Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease. Free Radic. Biol. Med. 31 (2001) 1120-1131
10. Goel A., Kunnumakkara A.B., and Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem. Pharmacol. 75 (2008) 787-809
11. Murakami K., Irie K., Ohigashi H., Hara H., Nagao M., Shimizu T., and Shirasawa T. Formation and stabilization model of the 42-mer Abeta radical: implications for the long-lasting oxidative stress in Alzheimer's disease. J. Am. Chem. Soc. 127 (2005) 15168-15174
12. Butterfield D.A., and Bush A.I. Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiol. Aging 25 (2004) 563-568
13. Cohen T., Frydman-Marom A., Rechter M., and Gazit E. Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry 45 (2006) 4727-4735
14. Gilead S., Wolfenson H., and Gazit E. Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin. Angew. Chem. Int. Ed Engl. 45 (2006) 6476-6480
15. Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., and Endo N. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 271 (1996) 6839-6844
16. Buettner G.R. Spin trapping: ESR parameters of spin adducts. Free Radic. Biol. Med. 3 (1987) 259-303
17. Dalal N.S., Newman J., Pack D., Leonard S., and Vallyathan V. Hydroxyl radical generation by coal mine dust: possible implication to coal workers' pneumoconiosis (CWP). Free Radic. Biol. Med. 18 (1995) 11-20
18. Huang X., Atwood C.S., Moir R.D., Hartshorn M.A., Tanzi R.E., and Bush A.I. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J. Biol. Inorg. Chem. 9 (2004) 954-960
19. Tabner B.J., El Agnaf O.M., Turnbull S., German M.J., Paleologou K.E., Hayashi Y., Cooper L.J., Fullwood N.J., and Allsop D. Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer's disease and familial British dementia. J. Biol. Chem. 280 (2005) 35789-35792
20. Ono K., Hasegawa K., Naiki H., and Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J. Neurosci. Res. 75 (2004) 742-750
21. Ono K., and Yamada M. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J. Neurochem. 97 (2006) 105-115
22. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., and Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 87 (2003) 172-181
23. Ono K., Hasegawa K., Naiki H., and Yamada M. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro. Biochim. Biophys. Acta 1690 (2004) 193-202
24. Schnitzer E., Pinchuk I., Bor A., Fainaru M., Samuni A.M., and Lichtenberg D. Lipid oxidation in unfractionated serum and plasma. Chem. Phys. Lipids 92 (1998) 151-170
25. Dobson C.M. Experimental investigation of protein folding and misfolding. Methods 34 (2004) 4-14
26. Masad A., Hayes L., Tabner B.J., Turnbull S., Cooper L.J., Fullwood N.J., German M.J., Kametani F., El Agnaf O.M., and Allsop D. Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?. FEBS Lett. 581 (2007) 3489-3493
27. Butterfield D.A., and Boyd-Kimball D. The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Biochim. Biophys. Acta 1703 (2005) 149-156
28. Cuajungco M.P., Faget K.Y., Huang X., Tanzi R.E., and Bush A.I. Metal chelation as a potential therapy for Alzheimer's disease. Ann. N. Y. Acad. Sci. 920 (2000) 292-304
29. Levy M., Porat Y., Bacharach E., Shalev D.E., and Gazit E. Phenolsulfonphthalein, but not phenolphthalein, inhibits amyloid fibril formation: implications for the modulation of amyloid self-assembly. Biochemistry 47 (2008) 5896-5904
30. Baum L., and Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J. Alzheimers Dis. 6 (2004) 367-377
31. Atwood C.S., Scarpa R.C., Huang X., Moir R.D., Jones W.D., Fairlie D.P., Tanzi R.E., and Bush A.I. Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. J. Neurochem. 75 (2000) 1219-1233
32. Cole G.M., Morihara T., Lim G.P., Yang F., Begum A., and Frautschy S.A. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models. Ann. N. Y. Acad. Sci. 1035 (2004) 68-84
33. Sang S., Hou Z., Lambert J.D., and Yang C.S. Redox properties of tea polyphenols and related biological activities. Antioxid. Redox. Signal. 7 (2005) 1704-1714
34. Weiner L.M. Oxygen radicals generation and DNA scission by anticancer and synthetic quinones. Methods Enzymol. 233 (1994) 92-105
35. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., and Bush A.I. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38 (1999) 7609-7616
36. Curtain C.C., Ali F., Volitakis I., Cherny R.A., Norton R.S., Beyreuther K., Barrow C.J., Masters C.L., Bush A.I., and Barnham K.J. Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276 (2001) 20466-20473
37. Guilloreau L., Combalbert S., Sournia-Saquet A., Mazarguil H., and Faller P. Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state. ChemBioChem. 8 (2007) 1317-1325
38. Moreira P.I., Santos M.S., Oliveira C.R., Shenk J.C., Nunomura A., Smith M.A., Zhu X., and Perry G. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS. Neurol. Disord. Drug Targets. 7 (2008) 3-10
39. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., and Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19 (1999) 1959-1964
40. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., and Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21 (2001) 8370-8377